▲ SURGE

Liminatus Pharma Inc.

+30.9%
LIMNNASDAQHealthcare2026-05-21
0.246
Close
0.188
Prev Close
+30.85%
Change
10.3x
Vol Ratio

Why It Surged

No related news available.

Related News

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit
Gurufocus2026-04-19
InMed Pharmaceuticals Reprices Investment Options to Attract Capital
Tipranks2026-04-27
Apimeds Pharmaceuticals And Lōkahi Therapeutics Secure FDA Type C Meeting To Discuss LT-100, Non-Opioid Biologic Candidate Being Developed For Osteoarthritis Treatment - Apimeds Pharmaceuticals (AMEX:APUS)
Benzinga2026-02-11
India's Alembic Pharma quarterly profit rises on strong U.S. generics demand
Reuters2026-05-15
InMed and Mentari announce all-stock merger deal (INM:NASDAQ)
Seekingalpha2026-05-19

Technical Analysis

Signals
BB Upper BreakMACD BullishAbove SMA20
Key Indicators
68.46RSI (14)
0.20SMA 20
0.17Bollinger Lower
0.23Bollinger Upper
0.20Bollinger Mid
0.00MACD
-0.00MACD Signal
0.00MACD Hist
View CompanyBack to Surge Stocks
Liminatus Pharma Inc. Surged +30.9% on 2026-05-21 — Analysis | Alpha Lenz